Skip to content

Study on the application of chloroprocaine hydrochloride in outpatient painless gastrointestinal endoscopy

Study on the application of chloroprocaine hydrochloride in outpatient painless gastrointestinal endoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085739
Enrollment
Unknown
Registered
2024-06-17
Start date
2024-06-17
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

propofol intravenous injection pain

Interventions

P:Inject chloroprocaine 30 seconds before propofol injection
C:Inject equal volume of normal saline

Sponsors

the Second People's Hospital of Wuhu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Patients undergoing elective gastroenteroscopy Age 18~64 years old BMI<25kg/m2 ASA?~?

Exclusion criteria

Exclusion criteria: Obstructive sleep apnea syndrome, uncontrolled severe hypertension, unstable angina, severe cardiac arrhythmia, abnormal liver and kidney function, moderate or above anemia, gastrointestinal obstruction with gastric content retention, resistance to propofol, Allergy to chloroprocaine, long-term use of sedative and analgesic drugs, mental illness or neurological disease, epilepsy.

Design outcomes

Primary

MeasureTime frame
Dosage of propofol;

Secondary

MeasureTime frame
Incidence of injection pain;BP, HR at 3min interval;The usage rate of ephedrine and atropine;SpO2 decrease event;Time of leaving the recovery room;Endometrists evaluate operating conditions;

Countries

China

Contacts

Public ContactShaolin Wang

the Second People’s Hospital of Wuhu

wuhuwsl@163.com+86 180 5531 6261

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026